Dr. Adam J. Bograd

Doctor Overview

Dr. Adam J. Bograd treats lung and chest diseases at Swedish Cancer Institute in Seattle, Washington. He is a board-certified thoracic surgeon who specializes in chest conditions, including pleural mesothelioma and other cancers.

As part of the institute’s mesothelioma team, Dr. Bograd uses minimally invasive surgery and multiple treatment approaches to help patients recover faster. This includes lung-sparing procedures like pleurectomy and decortication (P/D).

In addition to clinical work, Dr. Bograd has authored and co-authored many peer-reviewed publications. His research covers mesothelioma staging, lung cancer surgery and post-op patient recovery. He also serves on the Board of Directors for the Mesothelioma Applied Research Foundation, where he helps advance care and research for mesothelioma patients.

Doctor Fast Facts

Main Specialty: Thoracic Surgery

Other Interests & Specialties: Adult general thoracic surgery, cardiovascular surgery, esophageal cancer, lung cancer, pericardial conditions, pleural effusion, pleural mesothelioma, pneumothorax and thoracic surgical oncology.

Certifications, Awards & Accolades: American Board of Surgery, American Board of Thoracic Surgery, Castle Connolly Top Doctor (2024 – Present), Doris Duke International Clinical Research Fellowship, National Research Service Award (T32), Seattle Magazine Seattle Top Doctor Award (2023 – 2025)

Education & Experience:

• Medical Degree from Columbia University Vagelos College of Physicians and Surgeons
• Residency in Surgery at New York University Grossman School of Medicine
• Fellowship in Thoracic Oncology (T-Cell Engineering) Research at Memorial Sloan Kettering Cancer Center
• Fellowship in Thoracic Surgery at Memorial Sloan-Kettering Cancer Center

Publications

Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (Aim-high): an international, randomised, phase 3 trial. Lancet Respir Med. 2025 Oct;13(10):887–96.

Going to MARS may shorten our patient’s survival. J Thorac Cardiovasc Surg. 2025 June;169(6):1597–603.

Complicated pleural infection is associated with prolonged recovery and reduced functional ability. J Bronchology Interv Pulmonol. 2024 Oct 1;31(4):e0974.